Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 919-926

  Ichikawa, Motoki ^a   Johns, Terrance G ^a   Liu, Junliang ^a   Bernard, Claude C A ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENCEPHALITOGENIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN PEPTIDE 35 55; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMYELINATING DISEASE; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RAT; RELAPSE; REMISSION; SERUM; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CHRONIC DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; HINDLIMB; HYPERSENSITIVITY, DELAYED; IMMUNE SERA; INJECTIONS; MALE; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGODENDROGLIA; PEPTIDES; RATS; RATS, INBRED LEW; RECURRENCE;

EID: 0029959461     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bernard, C. C. A., and N. Kerlero de Rosbo. 1992. Multiple sclerosis: an autoimmune disease of multifactorial etiology. Curr. Opin. Immunol 4:760.
2. Bernard, C. C. A., T. E. Mandel, and I. R. Mackay. 1992. Experimental models of human autoimmune disease: overview and prototypes. In The Autoimmune Disease, Vol. II. N. R. Rose and I. R. Mackay, eds. Academic Press. San Diego, p. 47.
3. Tabira, T., and J. Kira. 1992. Strain and species differences of encephalitogenic determinants of myelin basic protein and proteolipid apoprotein. In Myelin: Biology and Chemistry. R. E. Materson, ed. CRC Press, Boca Raton, FL, p. 783.
4. Gardinier, M. V., P. Amiguet, C. Linington, and J.-M. Matthieu. 1992. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res. 33:177.
5. Pham-Dinh, D., M.-G. Mattei, J.-L. Nussbaum, G. Roussel, P. Pontarotti, N. Roeckel, I. H. Mather, K. Artzt, K. F. Lindahl, and A. Dautigny. 1993. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 90:7990.
6. Hilton, A. A., A. J. Slavin, D. J. Hilton, and C. C. A. Bernard. 1995. Cloning and molecular characterisation of human myelin oligodendrocyte glycoprotein. J. Neurochem. 65:309.
7. Brunner, C, H. Lassman, T. V. Waehneldt, J.-M. Matthieu, and C. Linington. 1989. Differential ultrastructural localization of myelin basic protein, myelin/oligodendrocyte glycoprotein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52:296.
8. Schluesener, H. J., R. A. Sobel, C. Linington, and H. L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:4016.
9. Linington, C., and H. Lassman. 1987. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titer to the myelin/oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 17:61.
10. Linington, C., M. Bradl, H. Lassman, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Palhol. 130:443.
11. Lassmann, H., C. Brunner, M. Bradl, and C. Linington. 1988. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. 75:566.
12. Linington, C., B. Engelhardt, G. Kapocs, and H. Lassman. 1992. Induction of persistently demyelinated lesion in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol. 40:219.
13. Kerlero de Rosbo, N., P. Honegger, H. Lassman, and J.-M. Matthieu. 1990. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin-oligodendrocyte glycoprotein (MOG). J. Neurochem. 55: 583.
14. Kerlero de Rosbo, N., R. Milo, M. B. Lees, D. Burger, C. C. A. Bernard, and A. Ben-Nun. 1993. Reactivity to myelin antigens in multiple sclerosis. J. Clin. Invest. 92:2602.
15. Linington, C., T. Berger, L. Perry, S. Weerth, D. Hinze-Selch, Y. Zhang, H.-C. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364.
16. Johns, T. G., N. Kerlero de Rosbo, K. Menon, S. Abo, M. F. Gonzales, and C. C. A. Bernard. 1995. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154:5536.
17. Abo, S., C. C. A. Bernard, M. Webb, T. G. Johns, A. Alafaci, L. D. Ward, R. J. Simpson, and N. Kerlero de Rosbo. 1993. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem. Mol. Biol. Int. 30:945.
18. Burger, D. A. J. Steck, C. C. A. Bernard, and N. Kerlero de Rosbo. 1993. Human myelin/oligodendrocyte glycoprotein: a new member of the L2/HNK-1 family. J. Neurochem. 61:1822.
19. Linington, C., M. Webb, and P. L. Woodhams. 1984. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6:387.
20. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, M. Brunetto, P. J. Barr, T. Miyamura, J. McHutchinson, and M. Houghton. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
22. Wekerle, H., K. Kojima, J. Lannes-Vieira, H. Lassmann, and C. Linington. 1994. Animal models. Ann. Neurol. 36:S47.
23. Kerlero de Rosbo, N., I. Mendel, and A. Ben-Nun. 1995. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25:985.
24. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951.
25. Kojima, K., T. Berger, H. Lassmann, D. Hinze-Seich, Y. Zhang, J. Gehrmann, K. Reske, H. Wekerle, and C. Linington. 1994. Experimental autoimmune panencephalitis and uveoretiritis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J. Exp. Med. 180:817.
26. Link, H. 1987. Cerebrospinal fluid in immunological CNS diseases. In Clinical Neuroimmunology. J. A. Aarli, W. M. H. Behan, and P. O. Behan, eds. Blackwell Scientific Publications, London., p. 79.
27. Mattson, D. H., R. P. Roos, and B. G. W. Arnason. 1980. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brain. Nature 287:335.
28. Bernard, C. C. A., E. Townsend, V. B. Randell, and H. G. Williamson. 1983. Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens? Clin. Exp. Immunol. 52:98.
29. Panitch, H. S., C. J. Hooper, and K. P. Johnson. 1980. CSF antibody to myelin basic protein: measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch. Neurol. 37:507.
30. Warren, K. G., I. Catz, E. Johnson, and B. Mielke. 1994. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann. Neurol. 35:280.
31. Esiri, M. M. 1977. Immunoglobulin-containing cells in multiple sclerosis plaques. Lancet 2:478.
32. Esiri, M. M. 1980. Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system. J. Neuropathol. Appl. Neurobiol. 6:9.
33. Adams, C. W. M. 1983. The general pathology of multiple sclerosis: morphological and chemical aspects of the lesions. In Multiple Sclerosis. J. F. Hallpike, C. W. M. Adams, and W. W. Tourtellotte, eds. Chapman and Hall, London. p.203.
34. Kerlero de Rosbo, N., and C. C. A. Bernard. 1989. Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination. J. Neurochem. 53:513.
35. Xiao, B.-G., C. Linington, and H. B. Link. 1991. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:91.
36. Bellone, M., P. I. Karachunski, N. Ostlie, S. Lei, and B. M. Conti-Tronconi. 1994. Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes. Eur. J. Immunol. 24:799.